rosiglitazone has been researched along with fluorodeoxyglucose f18 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hällsten, K; Huupponen, R; Janatuinen, T; Knuuti, J; Lönnqvist, F; Lönnroth, P; Nuutila, P; Parkkola, R; Rönnemaa, T; Viljanen, T; Virtanen, KA | 1 |
| Ferrannini, E; Hallsten, K; Iozzo, P; Kemppainen, J; Knuuti, J; Lonnqvist, F; Nuutila, P; Oikonen, V; Parkkola, R; Solin, O; Virtanen, KA | 1 |
| Ferrannini, E; Hällsten, K; Iozzo, P; Järvisalo, MJ; Lönnqvist, F; Nuutila, P; Parkkola, R; Rönnemaa, T; Viljanen, AP; Virtanen, KA | 1 |
| Bergman, J; Borra, R; Hällsten, K; Iozzo, P; Komu, M; Lautamäki, R; Nuutila, P; Parkkola, R; Sijens, PE | 1 |
| Cheong, SJ; Jeong, HJ; Kim, DW; Kim, EM; Kim, SL; Lee, CM; Lim, ST; Sohn, MH; Yim, CY | 1 |
| Bandy, D; Bird, NP; Brown, AP; Castiglia, M; Chen, K; Cunningham, VJ; Dixon, IJ; Gold, M; Hallett, WA; Jeter, B; Lai, RY; Lotay, N; Matthews, JC; Matthews, PM; Mistry, P; Nichols, TE; Rabiner, EA; Reiman, EM; Searle, G; Tzimopoulou, S; Whitcher, B; Zvartau-Hind, M | 1 |
3 trial(s) available for rosiglitazone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.
Topics: Adipose Tissue; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemic Agents; Insulin; Kinetics; Lactates; Lipids; Male; Metformin; Middle Aged; Placebos; Radiopharmaceuticals; Rosiglitazone; Thiazoles; Thiazolidinediones; Tomography, Emission-Computed; Weight Loss | 2003 |
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.
Topics: Adipose Tissue; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Rosiglitazone; Subcutaneous Tissue; Thiazolidinediones | 2005 |
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2010 |
3 other study(ies) available for rosiglitazone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
Topics: Adipose Tissue; Biological Transport; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemic Agents; Lipids; Liver; Male; Metformin; Middle Aged; Placebos; Radiopharmaceuticals; Regression Analysis; Rosiglitazone; Thiazolidinediones; Tomography, Emission-Computed | 2003 |
Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Fatty Liver; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemic Agents; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones | 2008 |
The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
Topics: Animals; Biological Transport; Cell Line, Tumor; Dimethyl Sulfoxide; Fluorodeoxyglucose F18; Gene Expression Regulation; Glucose; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Inflammation; Macrophages; Mice; Neoplasms; Positron-Emission Tomography; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2009 |